default author photo

Fangqin Xie

Fujian Center for Disease Control and Prevention

Fujian

China

SCHOLARLY PAPERS

1

DOWNLOADS

78

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell) Inactivated in Patients Over 60 Years of Age With Hypertension and Diabetes Mellitus

Number of pages: 25 Posted: 27 Jan 2022
Yun Tao Zhang, Haiping Chen, Jun Lv, Tao Huang, Ruizhi Zhang, Dongjuan Zhang, Linyun Luo, Sheng Wei, Xiaoqin Liu, Shangxiao Zhang, Qiuyue Mu, Rongdong Huang, Jiao Huang, Yanhui Xiao, Yun Kai Yang, Yuting Han, Hao Gong, Qinghu Guan, Fangqin Xie, Hui Wang, Liming Li and Xiaoming Yang
affiliation not provided to SSRN, China National Biotech Group Company Limited, Peking University - Department of Epidemiology and Biostatistics, Hunan Provincial Center for Disease Control and Prevention, Guizhou Center for Disease Control and Prevention, affiliation not provided to SSRN, China National Biotech Group Company Limited, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, China National Biotech Group Company Limited, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fujian Center for Disease Control and Prevention, Wuhan Institute of Biological Products, Co. Ltd., Peking University and National Engineering Technology Research Center of Combination Vaccines
Downloads 78 (816,709)

Abstract:

Loading...

COVID-19 vaccine (Vero cell) inactivated, elderly hypertensive population, elderly diabetic population, safety, immunogenicity